MedTrace Logo

End Nicotine Dependence Clinic

NCT03290430 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2020-04-14

No results posted yet for this study

Summary

The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Group Counseling

8 sessions over 4 weeks. Lasting 1-2 hours each

BEHAVIORAL

Individual Counseling

8 in person sessions over 4 weeks. Lasting 30-45 minutes each

BEHAVIORAL

Phone Counseling

8 phone sessions over 4 weeks. Lasting 30-45 minutes each

BEHAVIORAL

Video Counseling

8 video call sessions over 4 weeks. Lasting 30-45 minutes each

BEHAVIORAL

Texting support

Texts with smoking cessation support throughout the program

DRUG

Nicotine Replacement Therapy

Participants will receive up to 8 weeks of over-the-counter nicotine replacement therapy

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Monica Webb Hooper, PhD · Case Comprehensive Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-09
Primary Completion
2019-12-06
Completion
2020-01-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03290430 on ClinicalTrials.gov